NCT04514783

Brief Summary

Chronic wounds are common and carry out an important and often neglected burden not only to the individual, the family but also to the society as a whole. The therapeutic approach to the management of chronic wounds include wound bed preparation or wound dressing management. Wound bed preparation is a concept emphasizing a holistic and systematic approach to evaluate and remove barriers to the healing process to allow the wound healing process to progress normally. Debridement is an integrated part of wound bed preparation, achieving certain goals and, thus, creating a healthy wound bed, margins and peri-wound skin with the objective to promote and accelerate healing. Debridement is defined as the removal of foreign material and necrotic tissue from a wound and it can also help to stimulate wound healing. However, not all methods of debridement are the same. Each method has advantages and disadvantages that must be clearly understood. In the present clinical practice, there are several methods of wound debridement: autolytic, enzymatic, mechanical, surgical (sharp) and biologic. The most common method is the mechanical debridement. Currently a micro-water jet technique was introduced into clinical practice. The micro-water jet technique Debritom+ is an effective alternative to traditional instrument interventions performed with the scalpel and/or curette. A sterile liquid is expelled from a nozzle at a selected intensity and accurately sprayed onto the wound surface. The desired effect is the generation of targeted micro-bleedings to stimulate regeneration and healing processes while preserving the underlying healthy tissue. Today, there is no clinical evidence quantitatively comparing one debridement method over the other. Therefore the invesitgators propose a pilot study to measure the extent of tissue loss after debridement using Debritom+ micro-water jet technology versus traditional instrument debridement procedure using scalpel and curette.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 17, 2020

Completed
1.4 years until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

1.4 years

First QC Date

August 13, 2020

Last Update Submit

June 21, 2023

Conditions

Keywords

debridementwound carewound bed preparation

Outcome Measures

Primary Outcomes (1)

  • change in wound depth

    to determine the invasiveness of each debridement technique by the measures of wound dimensions (length, width, depth, area and volume) using Woundworks® device before and after debridement over a 6 weeks treatment period.

    6 weeks

Study Arms (2)

Group 2

OTHER

Use of scalpel and a spoon-shaped metal instrument (curette).

Other: Debridement with

Group 1

EXPERIMENTAL

Use of Debritom+ micro water jet technology

Device: Debridement with Debritom+ micro water jet device

Interventions

Visits to the outpatient wound-care center as directed by a physician. Wound care performed by the study nurse according to the study-protocol. Each necessary wound debridement will be the same and will be as follows: * Removal of old dressing * Woundworks® 3D imaging * Applying analgesic if necessary * Applying a soaked gaze with Sodium chloride (NaCl) 0.9% solution on the wound (5 minutes) * Debridement using Debritom+ micro water jet technology * Wound cleansing with NaCl 0.9% solution * Woundworks® 3D imaging * Application of new dressing (according to the wound healing phases, medical prescription) In the case debridement is no more required, wound dressing change will be performed as follows: * Removal of old dressing * Woundworks® 3D imaging * Wound cleansing with NaCl 0.9% solution * Application of new dressing (according to the wound healing phases, medical prescription)

Group 1

Visits to the outpatient wound-care center as directed by a physician. Wound care performed by the respective study nurse according to the study-protocol. Each necessary wound debridement will be the same and will be as follows: * Removal of old dressing * Woundworks® 3D imaging * Applying analgesic if necessary * Applying a soaked gaze with NaCl 0.9% solution on the wound (5 minutes) * Debridement using scalpel and curette * Wound cleansing with NaCl 0.9% solution * Woundworks® 3D imaging * Application of new dressing (according to the wound healing phases, medical prescription) In the case debridement is no more required, wound dressing change will be performed as follows: * Removal of old dressing * Woundworks® 3D imaging * Wound cleansing with NaCl 0.9% solution * Application of new dressing (according to the wound healing phases, medical prescription)

Group 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • An existing chronic wound requiring debridement
  • Age over 18 years
  • Proficiency in the French language

You may not qualify if:

  • Valid informed consent is not or cannot be given
  • Patients with wound presenting a dry necrosis
  • Arterial insufficiency stage III or IV
  • Patients under double anti-aggregation treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cité Génération Maison de santé

Onex, Canton of Geneva, 1213, Switzerland

Location

MeSH Terms

Interventions

Debridement

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Sebastian E Probst, Prof Dr

    HES-SO University of Applied Sciences and Arts Western Switzerland

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2020

First Posted

August 17, 2020

Study Start

January 1, 2022

Primary Completion

May 31, 2023

Study Completion

June 15, 2023

Last Updated

June 22, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

data will be anonymised

Locations